Dr. Sheth describes novel approaches for the prevention of recurrent intracerebral hemorrhage in brain hemorrhage survivors.
Recurrent intracerebral hemorrhage: new problem with an old target?
Caceres JA et al. Emerg Med Clin North Am. 2012;30:771-794. Woo D et al. Stroke. 2013;44:e120-125. Karsy M et al. Neurosurg Focus. 2017;42:E3. Joon An S et al. J Stroke. 2017;19:3-10. Poon MTC et al. J Neurol Neurosurg Psychiatry. 2014;85:660-667.
Dr. Sheth has received personal compensation for royalty, license fees, or contractual rights payments from
Alva Health. His institution (Yale) has received research support from Biogen, Novartis, Bard, Hyperfine.